Associations of apelin, visfatin, and urinary 8-isoprostane with severe hypertension in african americans: The mh-grid study

American Journal of Hypertension

Volumn 29, Issue 7, 2016, Pages 814-820

  Horbal, Steven R ^a   Seffens, William ^b   Davis, Adam R ^c   Silvestrov, Natalia ^b   Gibbons, Gary H ^d   Quarells, Rakale C ^b   Bidulescu, Aurelian ^a  

^a INDIANA UNIVERSITY   (United States)

^b MOREHOUSE SCHOOL OF MEDICINE   (United States)

^c NATIONAL HUMAN GENOME RESEARCH INSTITUTE   (United States)

^d NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Adipokines; African Americans; Apelin; Blood pressure; Hypertension; Severe hypertension; Urinary 8 isoprostane; Visfatin

Indexed keywords

8 ISOPROSTANE; APELIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; 8-EPI-PROSTAGLANDIN F2ALPHA; BIOLOGICAL MARKER; PROSTAGLANDIN F2 ALPHA;

ADULT; AFRICAN AMERICAN; ARTICLE; BLOOD ANALYSIS; COMMUNITY SAMPLE; CONTROLLED STUDY; CORRELATION COEFFICIENT; DATA BASE; DISEASE SEVERITY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RESISTANT HYPERTENSION; SEVERE HYPERTENSION; URINE LEVEL; ANALOGS AND DERIVATIVES; BLOOD; CASE CONTROL STUDY; STATISTICAL MODEL; STATISTICS AND NUMERICAL DATA; URINE;

ADULT; AFRICAN AMERICANS; APELIN; BIOMARKERS; CASE-CONTROL STUDIES; DINOPROST; FEMALE; HUMANS; HYPERTENSION; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE;

EID: 84981288347     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/hpw007     Document Type: Article

References (22)

1. Flack JM, Ferdinand KC, Nasser SA. Epidemiology of hypertension and cardiovascular disease in African Americans. J Clin Hypertens (Greenwich) 2003; 5(1 Suppl 1):5-11.
2. Nwankwo T, Yoon SS, Burt V, Gu Q. Hypertension Among Adults in the United States: National Health and Nutrition Examination Survey, 2011-2012 (Internet). Center for Disease Control and Prevention. http://www.cdc.gov/nchs/data/databriefs/db133.htm. 2013. Accessed 3 September 2015.
3. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Resistant hypertension: diagnosis, evaluation, and treatment a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Circulation 2008; 117:e510-526.
4. Dogru T, Sonmez A, Tasci I, Yilmaz MI, Erdem G, Erturk H, Bignol N, Kilic S, Ozgurtas T. Plasma visfatin levels in young male patients with uncomplicated and newly diagnosed hypertension. J Hum Hypertens 2007; 21:173-175.
5. Rosenstock J, Raskin P. Hypertension in diabetes mellitus. Cardiol Clin 1988; 6:547-560.
6. Trayhurn P, Wood IS. Signalling role of adipose tissue: adipokines and inflammation in obesity. Biochem Soc Trans 2005; 33(Pt 5):1078-1081.
7. Yudkin JS, Stehouwer CDA, Emeis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol 1999; 19:972-978.
8. Festa A, D'Agostino R, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes 2001; 25:1407-1415.
9. Engström G, Hedblad B, Stavenow L, Lind P, Janzon L, Lindgärde F. Inflammation-sensitive plasma proteins are associated with future weight gain. Diabetes 2003; 52:2097-2101.
10. Trayhurn P, Wood IS. Adipokines: inflammation and the pleiotropic role of white adipose tissue. Br J Nutr 2004; 92:347-355.
11. Przewlocka-Kosmala M, Kotwica T, Mysiak A, Kosmala W. Reduced circulating apelin in essential hypertension and its association with cardiac dysfunction. J Hypertens 2011; 29:971-979.
12. Miller ER, Erlinger TP, Sacks FM, Svetkey LP, Charleston J, Lin P-H, Appel LJ. A dietary pattern that lowers oxidative stress increases antibodies to oxidized LDL: results from a randomized controlled feeding study. Atherosclerosis 2005; 183:175-182.
13. Mazaherioun M, Hosseinzadeh-Attar MJ, Janani L, Vasheghani Farahani A, Rezvan N, Karbaschian Z, Hossein-Nezhad A. Elevated serum visfatin levels in patients with acute myocardial infarction. Arch Iran Med 2012; 15:688-692.
14. Dahl TB, Yndestad A, Skjelland M, Øie E, Dahl A, Michelsen A, Damas JK, Turnhelm SH, Ueland T, Smith C, Bendz B, Tonstad S, Gullestrad L, Frøland SS, Krohg-Sørensen K, Russel D, Aukrust P, Halvorsen B. Increased expression of visfatin in macrophages of human unstable carotid and coronary atherosclerosis possible role in inflammation and plaque destabilization. Circulation 2007; 115:972-980.
15. de Faria APC, Fontana V, Modolo R, Barbaro NR, Sabbatini AR, Pansani IF, Fereira-Melo SE, Moreno H. Plasma 8-isoprostane levels are associated with endothelial dysfunction in resistant hypertension. Clin Chim Acta 2014; 433:179-183.
16. Esteghamati A, Morteza A, Zandieh A, Jafari S, Rezaee M, Nakhjavani M, Jamali A, Seteghamati AR, Khalilzadeh O. The value of visfatin in the prediction of metabolic syndrome: a multi-factorial analysis. J Cardiovasc Trans Res 2012; 5:541-546.
17. Zulfikaroglu E, Isman F, Payasli A, Kilic S, Kucur M, Danisman N. Plasma visfatin levels in preeclamptic and normal pregnancies. Arch Gynecol Obstet 2010; 281:995-998.
18. Redon J. Hypertension in obesity. Nutr Metab Cardiovasc Dis 2001; 11:344-353.
19. Il'yasova D, Wang F, Spasojevic I, Base K, D'Agostino RB, Wagenknecht LE. Racial differences in urinary F2-isoprostane levels and the cross-sectional association with BMI. Obesity (Silver Spring) 2012; 20:2147-2150.
20. Gunes F, Akbal E, Cakir E, Akyurek O, Altunbas M, Ozbek M. Visfatin may be a novel marker for identifying stages of essential hypertension in advanced age patients. Intern Med 2012; 51:553-557.
21. Flack JM, Ference BA, Levy P. Should African Americans with hypertension be treated differently than non-African Americans? Curr Hypertens Rep 2014; 16:409.
22. Centers for Disease Control and Prevention. About BMI for Adults (Internet). http://www.cdc.gov/healthyweight/assessing/bmi/adult-bmi/index.html. 2015. Accessed 3 September 2015.